Your browser doesn't support javascript.
loading
Methods to Evaluate the Preclinical Safety and Immunogenicity of Genetically Modified Live-Attenuated Leishmania Parasite Vaccines.
Gannavaram, Sreenivas; Bhattacharya, Parna; Dey, Ranadhir; Ismail, Nevien; Avishek, Kumar; Salotra, Poonam; Selvapandiyan, Angamuthu; Satoskar, Abhay; Nakhasi, Hira L.
Afiliación
  • Gannavaram S; Laboratory of Emerging Pathogens, Division of Emerging and Transfusion Transmitted Diseases, Center for Biologics Evaluation and Research, Food and Drug Administration, 10903 New Hampshire Avenue, Silver Spring, MD, 20993, USA. Sreenivas.gannavaram@fda.hhs.gov.
  • Bhattacharya P; Laboratory of Emerging Pathogens, Division of Emerging and Transfusion Transmitted Diseases, Center for Biologics Evaluation and Research, Food and Drug Administration, 10903 New Hampshire Avenue, Silver Spring, MD, 20993, USA.
  • Dey R; Laboratory of Emerging Pathogens, Division of Emerging and Transfusion Transmitted Diseases, Center for Biologics Evaluation and Research, Food and Drug Administration, 10903 New Hampshire Avenue, Silver Spring, MD, 20993, USA.
  • Ismail N; Laboratory of Emerging Pathogens, Division of Emerging and Transfusion Transmitted Diseases, Center for Biologics Evaluation and Research, Food and Drug Administration, 10903 New Hampshire Avenue, Silver Spring, MD, 20993, USA.
  • Avishek K; National Institute of Pathology, Safdarjung Hospital Campus, New Delhi, 110029, India.
  • Salotra P; National Institute of Pathology, Safdarjung Hospital Campus, New Delhi, 110029, India.
  • Selvapandiyan A; Institute of Molecular Medicine, 254 Okhla Industrial Estate Phase 3, New Delhi, 110020, India.
  • Satoskar A; Departments of Pathology and Microbiology, Wexner Medical Center, The Ohio State University, Columbus, OH, 43210, USA.
  • Nakhasi HL; Laboratory of Emerging Pathogens, Division of Emerging and Transfusion Transmitted Diseases, Center for Biologics Evaluation and Research, Food and Drug Administration, 10903 New Hampshire Avenue, Silver Spring, MD, 20993, USA.
Methods Mol Biol ; 1403: 623-38, 2016.
Article en En | MEDLINE | ID: mdl-27076157
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Seguridad / Ingeniería Genética / Vacunas Antiprotozoos / Evaluación Preclínica de Medicamentos / Leishmania Límite: Animals Idioma: En Revista: Methods Mol Biol Asunto de la revista: BIOLOGIA MOLECULAR Año: 2016 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Seguridad / Ingeniería Genética / Vacunas Antiprotozoos / Evaluación Preclínica de Medicamentos / Leishmania Límite: Animals Idioma: En Revista: Methods Mol Biol Asunto de la revista: BIOLOGIA MOLECULAR Año: 2016 Tipo del documento: Article País de afiliación: Estados Unidos